<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 1999
----------------
Check here if Amendment [ ]; Amendment Number:
----------
This Amendment [Check only one.]: [ ] is a restatement
[ ] adds new holdings entries
Institutional Investment Manager Filing this Report:
Name: BVF, Inc.
---------------------------------------------------------
Address: 227 West Monroe Street, Suite 4800
---------------------------------------------------------
Chicago, Illinois 60606
---------------------------------------------------------
Form 13F File Number: 28-6800
----
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Mark N. Lampert
---------------------------------------------------------
Title: President
---------------------------------------------------------
Phone: (312) 263-7777
---------------------------------------------------------
Signature, Place and Date of Signing:
/s/ MARK N. LAMPERT San Francisco, California 5/14/99
------------------- ------------------------- -------
[Signature] [City, State] [Date]
Report Type (Check only one):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s)).
<PAGE>
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
Report Summary:
Number of Other Included Managers: 1
---------------------------
Form 13F Information Table Entry Total: 31
---------------------------
Form 13F Information Table Value Total: $153,581
---------------------------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings
and list entries.]
No. Form 13F File Number Name
1. 28-6770 BVF Partners L.P.
----- ---- -------------------------------------
<PAGE>
<TABLE>
<CAPTION>
------------------
Page 3 of 6 (SEC USE ONLY)
FORM 13F
NAME OF REPORTING MANAGER: BVF INC.
----------- ------------------
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN 1: COLUMN 2: COLUMN 3: COLUMN 4: COLUMN 5: COLUMN 6: COLUMN 7: COLUMN 8:
NAME OF ISSUER TITLE OF CUSIP VALUE ---------------------- INVESTMENT OTHER VOTING AUTHORITY
CLASS (X$1000) SHRS SH/ PUT/ DISCRETION MANAGERS ------------------------------
PRN PRN CALL SOLE SHARED NONE
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Advanced Magnetics Com 00753P103 3,182 909,235 Sh Defined 1 909,235
Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Aquila Biopharm Inc Com 03839F107 681 330,126 Sh Defined 1 330,126
- -----------------------------------------------------------------------------------------------------------------------------------
Autoimmune Inc Com 052776101 3,062 1,360,800 Sh Defined 1 1,360,800
- -----------------------------------------------------------------------------------------------------------------------------------
Avant Com 053491106 457 292,766 Sh Defined 1 292,766
Immunotherapeutics
Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Biochem Pharma Inc Com 09058T108 541 25,400 Sh Defined 1 25,400
- -----------------------------------------------------------------------------------------------------------------------------------
Cadus Pharaceutical Com 127639102 200 200,000 Sh Defined 1 200,000
Corp
- -----------------------------------------------------------------------------------------------------------------------------------
Cambridge Com 132426107 602 872,500 Sh Defined 1 872,500
Nueroscience Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Cima Labs Inc Com 171796105 1,871 611,100 Sh Defined 1 611,100
- -----------------------------------------------------------------------------------------------------------------------------------
Clinichem Dev Inc Cl A 186906103 1,752 257,794 Sh Defined 1 257,794
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTAL 12,348
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
------------------
Page 4 of 6 (SEC USE ONLY)
FORM 13F
NAME OF REPORTING MANAGER: BVF INC.
----------- ------------------
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN 1: COLUMN 2: COLUMN 3: COLUMN 4: COLUMN 5: COLUMN 6: COLUMN 7: COLUMN 8:
NAME OF ISSUER TITLE OF CUSIP VALUE ---------------------- INVESTMENT OTHER VOTING AUTHORITY
CLASS (X$1000) SHRS SH/ PUT/ DISCRETION MANAGERS ------------------------------
PRN PRN CALL SOLE SHARED NONE
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Cortech Inc Com 22051J100 1,114 183,774 Sh Defined 1 183,774
- -----------------------------------------------------------------------------------------------------------------------------------
Corvas Intl Inc Com 221005101 7,319 2,927,743 Sh Defined 1 2,927,743
- -----------------------------------------------------------------------------------------------------------------------------------
Creative Biomolecules Com 225270107 823 356,000 Sh Defined 1 356,000
Inc.
- -----------------------------------------------------------------------------------------------------------------------------------
Genome Therapeutics Com 372430108 5,529 1,769,285 Sh Defined 1 1,769,285
Corp
- -----------------------------------------------------------------------------------------------------------------------------------
Guilford Com 401829106 17,577 1,545,274 Sh Defined 1 1,545,274
Pharmaeceuticals Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Microcide Com 595018102 7,390 1,791,600 Sh Defined 1 1,791,600
Pharmaceuticals Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Molecular Biosystems Com 608513107 256 97,500 Sh Defined 1 97,500
Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Neurocrine Com 64125C109 104 20,000 Sh Defined 1 20,000
Biosciences Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Neurogen Corp Com 64124E106 17,385 1,626,706 Sh Defined 1 1,626,706
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTAL 57,497
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
------------------
Page 5 of 6 (SEC USE ONLY)
FORM 13F
NAME OF REPORTING MANAGER: BVF INC.
----------- ------------------
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN 1: COLUMN 2: COLUMN 3: COLUMN 4: COLUMN 5: COLUMN 6: COLUMN 7: COLUMN 8:
NAME OF ISSUER TITLE OF CUSIP VALUE ---------------------- INVESTMENT OTHER VOTING AUTHORITY
CLASS (X$1000) SHRS SH/ PUT/ DISCRETION MANAGERS ------------------------------
PRN PRN CALL SOLE SHARED NONE
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
NPS Pharmaceuticals Com 62936P103 15,402 2,053,600 Sh Defined 1 2,053,600
Inc
- -----------------------------------------------------------------------------------------------------------------------------------
OSI Pharmaceuticals Com 671040103 10,939 2,187,790 Sh Defined 1 2,187,790
Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Progenics Com 743187106 10,867 724,480 Sh Defined 1 724,480
Pharmaceuticals Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Protein Polymer Com 743697104 283 412,000 Sh Defined 1 412,000
Technologies
- -----------------------------------------------------------------------------------------------------------------------------------
QLT Phototherapeutics Com 746927102 7,826 192,060 Sh Defined 1 192,060
Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Repligen Corp Com 759916109 4,441 1,450,000 Sh Defined 1 1,450,000
- -----------------------------------------------------------------------------------------------------------------------------------
Sibia Neurosciences Com 825732100 5,217 1,043,400 Sh Defined 1 1,043,400
Inc
- -----------------------------------------------------------------------------------------------------------------------------------
Synaptic Com 87156R109 9,057 1,317,317 Sh Defined 1 1,317,317
Pharmaceutical Corp
- -----------------------------------------------------------------------------------------------------------------------------------
Titan Pharmaceuticals Com 888314101 3,759 1,002,273 Sh Defined 1 1,002,273
Inc Del
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTAL 67,791
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
------------------
Page 6 of 6 (SEC USE ONLY)
FORM 13F
NAME OF REPORTING MANAGER: BVF INC.
----------- ------------------
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN 1: COLUMN 2: COLUMN 3: COLUMN 4: COLUMN 5: COLUMN 6: COLUMN 7: COLUMN 8:
NAME OF ISSUER TITLE OF CUSIP VALUE ---------------------- INVESTMENT OTHER VOTING AUTHORITY
CLASS (X$1000) SHRS SH/ PUT/ DISCRETION MANAGERS ------------------------------
PRN PRN CALL SOLE SHARED NONE
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Amgen Inc Com 031162950 4,043 54,000 Put Defined 1 54,000
- -----------------------------------------------------------------------------------------------------------------------------------
Biogen Inc. Com 090597955 3,372 29,500 Put Defined 1 29,500
- -----------------------------------------------------------------------------------------------------------------------------------
Centocor Inc Com 152342951 517 14,000 Put Defined 1 14,000
- -----------------------------------------------------------------------------------------------------------------------------------
Merck & Co Inc Com 589331957 8,013 100,000 Put Defined 1 100,000
- -----------------------------------------------------------------------------------------------------------------------------------
COLUMN TOTAL 15,945
- -----------------------------------------------------------------------------------------------------------------------------------
AGGREGATE TOTAL 153,581
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
